Accessibility Menu
Bausch Health Companies logo

Bausch Health Companies

(NYSE) BHC

Current Price$4.79
Market Cap$1.97B
Since IPO (1994)+1,319%
5 Year-84%
1 Year-26%
1 Month-12%

Bausch Health Companies Financials at a Glance

Market Cap

$1.97B

Revenue (TTM)

$10.55B

Net Income (TTM)

-$1.19B

EPS (TTM)

-$3.25

P/E Ratio

-1.63

Dividend

$0.00

Beta (Volatility)

1.23 (Average)

Price

$4.79

Volume

12,661,385

Open

$5.28

Previous Close

$4.76

Daily Range

$4.71 - $5.95

52-Week Range

$4.57 - $8.69

Estimated Earnings Date

Jul 29, 2026

BHC: Motley Fool Moneyball Superscore

45

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bausch Health Companies

Industry

Pharmaceuticals

Employees

20,300

CEO

Thomas J. Appio

Headquarters

Laval, QC H7L 4A8, CA

BHC Financials

Key Financial Metrics (TTM)

Gross Margin

61.67%

Operating Margin

22.91%

Net Income Margin

-11.27%

Return on Equity

120.75%

Return on Capital

10.76%

Return on Assets

-4.86%

Earnings Yield

-61.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.97B

Shares Outstanding

373.48M

Volume

12.66M

Avg. Volume

1.81M

Financials (TTM)

Gross Profit

$6.51B

Operating Income

$2.42B

EBITDA

$1.97B

Operating Cash Flow

$1.42B

Capital Expenditure

-$430.39M

Free Cash Flow

$989.53M

Cash & ST Invst.

$1.30B

Total Debt

$20.80B

Bausch Health Companies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$2.49B

+10.5%

Gross Profit

$1.52B

+17.4%

Gross Margin

61.21%

N/A

Market Cap

$1.97B

N/A

Market Cap/Employee

$95.26K

N/A

Employees

20,700

N/A

Net Income

-$1.40B

-2326.8%

EBITDA

-$647.90M

-210.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.30B

+14.6%

Total Debt

$20.80B

-3.3%

Accounts Receivable

$2.19B

+5.7%

Inventory

$1.60B

-0.7%

Long Term Debt

$19.90B

-6.3%

Short Term Debt

$900.00M

+219.1%

Return on Assets

-4.86%

N/A

Return on Invested Capital

12.11%

N/A

Free Cash Flow

$83.00M

-4.6%

Operating Cash Flow

$230.00M

+9.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANIPANI Pharmaceuticals, Inc.
$84.50+1.46%
HCMHUTCHMED (China) Limited
$10.17-1.17%
MLYSMineralys Therapeutics, Inc.
$26.68+1.29%
XRAYDENTSPLY SIRONA Inc.
$11.01+2.13%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$192.53-0.02%
AALAmerican Airlines Group
$17.87+0.02%
SPCXSpace Exploration Technologies
$153.23+0.00%
HLHecla Mining
$15.54+0.03%

Questions About BHC

What is the current price of Bausch Health Companies?

Bausch Health Companies is trading at $4.76 per share.

What is the 52-week range for Bausch Health Companies?

Over the past 52 weeks, Bausch Health Companies has traded between $4.57 and $8.69.

How much debt does Bausch Health Companies have?

As of the most recent reporting period, Bausch Health Companies reported total debt of $20.80B.

How much cash does Bausch Health Companies have on hand?

Bausch Health Companies reported $1.31B in cash and cash equivalents in its most recent financial results.

What is Bausch Health Companies’s dividend yield?

Bausch Health Companies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.